This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Registered conference delegates have access to the co-located parallel conferences:
- Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2017
- Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2017
- Point-of-Care Diagnostics Global Health and Emerging Viral Diseases World Congress2017
- Biosecurity and Biosensors Summit 2017
The Exhibit Hall is Co-Located with the Conference Tracks and is open October 2-4, 2017.
Register for the conference： Select Biosciences, Inc.